| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 2,000 shares
@ $8.63, valued at
$17.3k
|
|
| 08/24/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $9.97, valued at
$10k
|
|
| 08/08/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 2,000 shares
@ $10.55, valued at
$21.1k
|
|
| 07/25/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $11.69, valued at
$11.7k
|
|
| 04/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/20/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $12.12, valued at
$12.1k
|
|
| 02/22/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 600 shares
@ $16.53, valued at
$9.9k
|
|
| 02/14/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $18.68, valued at
$18.7k
|
|
| 01/31/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 2,000 shares
@ $19.35, valued at
$38.7k
|
|
| 01/24/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,500 shares
@ $17.37, valued at
$26.1k
|
|
| 01/10/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,500 shares
@ $15.18, valued at
$22.8k
|
|
| 01/03/2023 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 4,000 shares
@ $15.19, valued at
$60.8k
|
|
| 12/20/2022 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $13.01, valued at
$13k
|
|
| 12/13/2022 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 2,000 shares
@ $13.11, valued at
$26.2k
|
|
| 12/06/2022 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $13.84, valued at
$13.8k
|
|
| 11/04/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/17/2022 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 3,000 shares
@ $9.75, valued at
$29.3k
|
|
| 10/11/2022 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 2,000 shares
@ $9.72, valued at
$19.4k
|
|
| 10/04/2022 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $9.46, valued at
$9.5k
|
|
| 10/03/2022 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 1,000 shares
@ $9.23, valued at
$9.2k
|
|
| 06/27/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/15/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/22/2022 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 6,000 shares
@ $16.09, valued at
$96.5k
|
|
| 04/21/2022 |
4
| Patel Snehal (CEO and CFO) has filed a Form 4 on Greenwich LifeSciences, Inc.|
Txns:
| Bought 6,000 shares
@ $16.74, valued at
$100.4k
|
|
|